1546-0096-6-11 1546-0096 Review <p>A comprehensive review of the genetics of juvenile idiopathic arthritis</p> Prahalad Sampath prahal@genetics.utah.edu Glass N David david.glass@cchmc.org

Assistant Professor of Pediatrics, Division of Immunology and Rheumatology, Department of Pediatrics, University of Utah School of Medicine, P.O Box 581289 Salt Lake City, UT 84158-1289, USA

Professor of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., MLC 7030, Cincinnati, OH 45229, USA

 Pediatric Rheumatology 1546-0096 2008 6 1 11 http://www.ped-rheum.com/content/6/1/11 18644131 10.1186/1546-0096-6-11 26 3 2008 21 7 2008 21 7 2008 2008 Prahalad and Glass; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Juvenile idiopathic arthritis (JIA) is the most common chronic arthropathy of childhood which is believed to be influenced by both genetic and environmental factors. The progress in identifying genes underlying JIA susceptibility using candidate gene association studies has been slow. Several associations between JIA and variants in the genes encoding the human leukocyte antigens (HLA) have been confirmed and replicated in independent cohorts. However it is clear that genetic variants outside the HLA also influence susceptibility to JIA. While a large number of non-HLA candidate genes have been tested for associations, only a handful of reported associations such as PTPN22 have been validated. In this review we discuss the principles behind genetic studies of complex traits like JIA, and comprehensively catalogue non-HLA candidate-gene association studies performed in JIA to date and review several validated associations. Most candidate gene studies are underpowered and do not detect associations, and those that do are often not replicated. We also discuss the principles behind genome-wide association studies and discuss possible implications for identifying genes underlying JIA. Finally we discuss several genetic variants underlying multiple clinically distinct autoimmune phenotypes.

Juvenile idiopathic arthritis rers to a group of chronic arthropathies of childhood1. According to the International League of Associations for Rheumatology criteria, JIA comprises seven subtypes2. These include systemic JIA (sJIA), oligoarticular JIA, rheumatoid factor (RF)-negative polyarticular JIA, RF-positive polyarticular JIA, enthesitis related arthritis (ERA), psoriatic arthritis and undifferentiated JIA. The relatively homogeneous subtypes of JIA share clinical features with other chronic autoimmune disorders such as rheumatoid arthritis (RA), psoriasis or spondyloarthropathies 3. Autoimmune disorders are relatively common in the population, estimated to have a prevalence of about ~5% in the US. While clinical and laboratory features distinguish many of these autoimmune disorders, there is accumulating evidence to support the hypothesis that clinically distinct autoimmune phenotypes share common genetic susceptibility factors. In this review, we will examine the genetic factors that underlie JIA susceptibility, and discuss some of the genetic factors that underlie multiple autoimmune phenotypes.

JIA is an autoimmune disorder

All subtypes of JIA are characterized by persistent joint swelling caused by an accumulation of synovial fluid and thickening of the synovial lining. There is evidence to support the involvement of different components of the immune system in the etiopathogenesis of JIA. The synovial tissue contains various inflammatory cells including neutrophils, plasma cells, dendritic cells and a high proportion of activated T-cells 456. The recruitment of pro-inflammatory cells into the synovium of a child with JIA is believed to be mediated by chemokines that selectively attract Th1 T-cells 789. These T-cells are characterized by the production of interleukin (IL)-2, interferon-γ, and tumor necrosis factor (TNF)-β. Many other autoimmune disorders including RA, inflammatory bowel disease (IBD), psoriasis, and type 1 diabetes mellitus (T1DM) are also associated with Th1-dominant responses1011. Several studies have demonstrated that Th1 cytokines also predominate in the synovial tissue and synovial fluid samples from children with JIA 12131415. Pro-inflammatory cytokines including sCD154 are significantly elevated in sera of children with JIA as well 16. Thus, there is compelling evidence that activated T-lymphocytes play a role in the pathogenesis of JIA.

Involvement of the other components of the immune system is also evident in JIA. For instance a significant proportion of children with JIA have antinuclear antibodies, and some children have rheumatoid factors, suggesting a role of the humoral component of the immune system. The predominance of neutrophils in the synovial fluid of children with JIA, elevated levels of monocyte derived inflammatory cytokines, and complement activation have led to investigations of the involvement of innate immune system in JIA. Using gene expression analysis, Jarvis et al have found that neutrophils in children with polyarticular JIA show differences in levels of expression of over 700 genes compared to healthy controls 17. These differences persisted despite clinical responses to pharmacological therapy, suggesting that neutrophils might be intrinsically involved in the pathogenesis of polyarticular subtypes of JIA. Together, these data point to the role of aberrant immune/inflammatory responses in JIA.

Evidence that genetic factors underlie JIA susceptibility

Twin and family studies have provided evidence for genetic contributions to susceptibility of JIA. Twin studies have shown that the monozygotic twin concordance rates for JIA range between 25 to 40 %, a risk that is substantially greater than the population prevalence of 1 in 1000 18. An analysis of twin pairs in a national JIA registry showed that at least 80 % of the twin pairs in the registry were monozygotic, when one would expect only a third to be monozygotic 19. Similarly examination of affected sibling pairs with JIA reveals concordance for disease onset, and disease course2021. Furthermore siblings were more likely to develop JIA at the same age of onset, rather than the same calendar year. The prevalence of JIA among siblings of probands is about 15–30 times that of the general population prevalence2223. Finally a computerized probabilistic record-linking analysis identified several clusters of children with JIA sharing common ancestors 23. Together these studies provide compelling evidence for a substantial genetic component underlying JIA susceptibility.

JIA is a complex genetic trait

Complex genetic traits are those phenotypes that do not exhibit classic Mendelian inheritance patterns which could be attributed to variants in a single gene locus2425. Complex traits are often believed to be determined by a number of genetic and environmental factors. While increased prevalence of JIA has been shown in twins or siblings of probands with JIA, parent-offspring pairs and extended multiplex JIA families are relatively uncommon in JIA. Relatives of JIA probands have increased prevalence of other autoimmune disorders 2627. The best characterized genetic factors, i.e., polymorphisms in the genes encoding human leukocyte antigen (HLA -DR) have been estimated to account for only 17 % of the proportion of sibling recurrence risk in JIA28. These factors support the notion that JIA is a complex phenotype22.

Exploring the genetic basis of disease

Linkage and association studies are analytical approaches used to dissect the genetic basis of common diseases. Both studies rely on the same principles and assumptions, namely the co-inheritance of polymorphisms linked to a disease allele 2930. Linkage studies test whether a phenotype and a marker allele show correlated transmission within a pedigree24. Linkage analysis requires large collections of multiplex families, in which multiple family members have the phenotype of interest. Association studies test whether a phenotype and a marker allele show correlated occurrence in a population24. Association studies compare unrelated affected and unaffected individuals within a population. An allele at a locus of interest is associated with a phenotype if it occurs at a significantly higher (or lower) frequency among cases compared to controls. The selection of controls is very critical in case-control association studies, since results can be affected by population stratification. Family-based association studies, including the transmission disequilibrium test (TDT) are not affected by population stratification, since they use untransmitted alleles as controls within families. When linkage or association between a marker and a disease is detected, it implies either that the marker is the disease allele, or that the marker is in linkage disequilibrium (LD) with the disease allele. LD is a non-random association of alleles at two or more loci and is a measure of co-segregation of alleles in a population3132.

The search for genetic factors underlying susceptibility to complex traits can be classified as functional candidate gene studies or genome-wide studies. Functional candidate-gene studies begin by selecting genes whose known functions suggest that they could be influencing the phenotype of interest. In genome-wide studies, the genome is searched for susceptibility loci, and no assumptions are made about the candidacy of particular genes or genomic regions. Until now most association studies could examine only a small fraction of the sequence variation in an affected individual. However, advances in genome technologies, and the availability of haplotype and LD information from the HapMap project now facilitate comprehensive genome-wide searches for genetic influences 29.

Genes underlying JIA susceptibility

Genetic variants underlying JIA susceptibility have been reviewed extensively183334353637. The major histocompatibility complex (MHC) region on chromosome 6 is packed with over 200 genes, many of which are essential to the immune system. Numerous associations between HLA polymorphisms and JIA subtypes have been reported in multiple populations (Table 1). Within the HLA complex there are genes encoding class I (HLA A, B and C), and class II (HLA-DR, DP and DQ) molecules. The class I allele HLA-A2 is associated with different JIA subtypes, especially in those with early onset3839. HLA-B27 is associated with enthesitis related JIA 394041. Oligoarticular JIA is the subtype with the most HLA class II associations. Oligoarticular JIA is positively associated with HLA DRB1*01, DRB1*08, DRB1*11, DRB1*13, DPB1*02 and DQB1*04383941424344. HLA DRB1*04 and DRB1*07 are seen less frequently in children with oligoarticular JIA than controls, suggesting that they are protective38394144. Polyarticular RF negative JIA is associated with DRB1*08 and DPB1*03 4144. Polyarticular RF-positive JIA, which is phenotypically similar to adult RA, is associated with DRB1*04, DQA1*03, and DQB1*034144. Psoriatic arthritis was found in the study by Thomson et al to be associated with HLA DRB1*01, and DQA1*010141. Associations between sJIA and HLA DRB1*04 have also been reported4546. A recent study reported an association between a polymorphism in the HLA-G region and JIA, with a pronounced association in female subjects 47. While some associations appear to be secondary to LD (for instance HLA DR and DQ alleles), most associations are not explained by LD, suggesting that several HLA loci independently contribute to susceptibility of JIA or its subtypes. A study involving over 600 children with JIA and 254 ethnicity-matched healthy controls confirmed several previously reported HLA associations, and also identified age-specific windows of susceptibility for the different HLA alleles39. This study also demonstrated that the number of susceptibility alleles was inversely proportional to the age of onset of JIA. Among children who carried HLA-A2, DPB1*0201, and one susceptible -DR allele the median age of onset of oligoarticular JIA was just 2.4 years.

<p>Table 1</p>

Associations between JIA subtypes and different HLA alleles.

Phenotype

Alleles conferring susceptibility

Protective alleles

Oligoarticular

A2, DRB1*01, DRB1*08, DRB1*11, DRB1*13, DPB1*02, DQA1*04, DQB1*04

DRB1*04, DRB1*07, DQA1*03

Polyarticular RF+

DRB1*04, DQA1*03, DQB1*03

DQA1*02

Polyarticular RF-

A2, DRB1*08, DQA1*04, DPB1*03

Psoriatic

DRB1*01, DQA1*0101

DRB1*04, DQA1*03

ERA

B27, DRB1*01, DQA1*0101, DQB1*05

Systemic

DRB1*04, DRB1*11, DQA1*05

Non HLA Associations

A number of non-HLA genes have been tested for association with JIA. Only a few of these have been replicated in additional cohorts. Some of these are reviewed by Phelan et al 33. A systematic review of the literature suggests that about 100 different non-HLA candidate loci have been investigated for associations with JIA, in over 150 tests for genetic association in different cohorts (Table 2). Although ~25 % of all tests reported finding an association, independent confirmations are found for only a handful of candidate genes including PTPN22, MIF, SLC11A6, WISP3, and TNFA (Table 3). Many studies analyze JIA as a single phenotype. While combining clinically distinct entities such as systemic JIA and oligoarticular JIA might confound the results, stratification of subjects leads to further loss of power. Finally most studies do not correct for multiple comparisons, which might result in false positive associations that cannot be ultimately confirmed. The ranges of cases in these studies varied from 33 individuals to 950 individuals with JIA, and the number of controls ranged from 40 to 1952. The median number of cases was 130, while the median number of controls was 276. Only a few studies used more than 800 cases of JIA. These observations suggest that most of these studies are underpowered to detect associations with modest odds ratios (OR) (Table 4). Results of studies in other complex genetic traits suggest that most associated variants have only a modest OR of about 1.5. These observations reinforce the importance of properly performed and reported studies including the capacity to replicate.

<p>Table 2</p>

Non-HLA candidate markers tested for association with JIA.

Marker

ASSN

Cases

Controls

Design

NOTES

Author

ID

ACE

Y

82

48

CC

Insertion/deletion polymorphism

Alsaid

119

ADAM33

N

86

270

CC

Schubert

120

ADRB2

N

86

270

CC

Schubert

120

ADRB2

N

348

448

CC

Pont-Kingdon

121

Alpha 1 AT

Y

96

4565

CC

Arnaud

122

BV13S2

N

120

500

CC

Epplen

56

BV62&

N

120

500

CC

Epplen

56

BV6S3

N

120

500

CC

Epplen

56

CARD15

N

86

270

CC

Schubert

120

CBG

N

463

276

CC

Donn

123

CCR3

N

86

270

CC

Schubert

120

CCR5

N

86

270

CC

Schubert

120

CCR5

Y

819

TDT

Protective

Prahalad

79

CCR5

N

524

658

CC

Lindner

80

CCR5

Y

101

104

CC

Positive association in systemic+poly

Scheibel

124

CD3D

N

120

500

CC

Epplen

56

CD40L

N

120

500

CC

Epplen

56

CRH

N

463

276

CC

Donn

123

CSF2

N

86

270

CC

Schubert

120

CTLA4

Y

197

362

CC

Miterski

59

CTLA4

N

72

475

CC

Suppiah

125

CTLA4

N

86

270

CC

Schubert

120

CTLA4

N

818

518

CC

Prahalad

113

CTSL2

N

530

559

CC

Viken 2007

126

CYP19

N

463

276

CC

Donn

123

D17S795

N

173

416

CC

Miterski

59

D17S807

N

172

412

CC

Miterski

59

D17S821

N

173

412

CC

Miterski

59

DDR1

N

135

199

TDT

Zeggini

127

ESR1

N

463

276

CC

Donn

123

FAS

N

342

255

CC

Donn

128

FCER1B

N

86

270

CC

Schubert

120

FCRL3

Y

524

1030

CC

Association seen in poly JIA subset

Eike

129

FGFA

N

120

500

CC

Epplen

56

FOXp3

N

761

402

CC

Eastell

130

GSTM1

N

103

90

CC

Rohr

131

GSTP1

N

103

90

CC

Rohr

131

GSTT1

Y

103

90

CC

Rohr

131

GZMB

N

133

384

CC

Only systemic JIA studied

Donn

95

IFNA

N

120

500

CC

Epplen

56

IFNA1

N

417

276

CC

Donn

69

IFNG

N

417

276

CC

Donn

69

IFNG

N

165

395

CC

Miterski

59

IFNG

N

130

103

CC

Cinek

132

IgA def

Y

1673

CC

Data derived from several studies.

Cassidy

133

IKBL

N

170

389

CC

Miterski

59

IL1 cluster

Y

235

335

CC

Only systemic JIA studied. Two stage study

Stock

71

IL1R cluster

Y

235

335

CC

Only systemic JIA studied. Two stage study

Stock

71

IL1A

N

417

276

CC

Donn

69

IL1A

Y

269

99

CC

Association with early onset oligo JIA

McDowell

68

IL1A

N

130

103

CC

Cinek

132

IL1A

N

120

500

CC

Epplen

56

IL1B

Y

107

630

CC

Cimaz

134

IL1B

N

130

103

CC

Non-significant association reported.

Cinek

132

IL1R

N

130

103

CC

Cinek

132

IL1RA

N

107

630

CC

Cimaz

134

IL1RN

Y

235

306

CC

Vencovsky

135

IL2

N

417

276

CC

Donn

69

IL2

N

86

270

CC

Schubert

120

IL2

N

130

103

CC

Cinek

132

IL2

N

120

500

CC

Epplen

56

IL3

N

86

270

CC

Schubert

120

IL4

N

417

276

CC

Donn

69

IL4

N

86

270

CC

Schubert

120

IL4

N

72

165

CC

Trend in female cases

Suppiah

136

IL4

Y

130

103

CC

Cinek

132

IL4R

N

72

165

CC

Trend in female cases

Suppiah

136

IL4RA

N

130

103

CC

Cinek

132

IL5RA

N

120

500

CC

Epplen

56

IL6

N

417

276

CC

Donn

69

IL6

Y

222

TDT

Only systemic JIA patients studied

Ogilvie

76

IL6

N

86

270

CC

Schubert

120

IL6

N

130

103

CC

Cinek

132

IL8

N

86

270

CC

Schubert

120

IL10

N

417

276

CC

Donn

69

IL10

N

86

270

CC

Schubert

120

IL10

Y

172

473

CC

Only systemic JIA patients studied

Fife

137

IL10

N

130

103

CC

Cinek

132

IL12

N

130

103

CC

Cinek

132

IL13

N

86

270

CC

Schubert

120

IL15

Y

107

270

CC

Bierbaum

138

IL18

N

86

270

CC

Schubert

120

IL18

Y

33

176

CC

sugiura

139

IL1A

N

417

276

CC

Donn

69

IL1A

Y

269

99

CC

Association with early onset oligo JIA

McDowell

68

IL1A

N

130

103

CC

Cinek

132

IL1A

N

120

500

CC

Epplen

56

IL1B

Y

107

630

CC

Cimaz

134

IL1B

N

130

103

CC

Non-significant association reported.

Cinek

132

IL1R

N

130

103

CC

Cinek

132

IL1RA

N

107

630

CC

Cimaz

134

IL1RN

Y

235

306

CC

Vencovsky

135

IL2

N

417

276

CC

Donn

69

IL2

N

86

270

CC

Schubert

120

IL2

N

130

103

CC

Cinek

132

IL2

N

120

500

CC

Epplen

56

IL3

N

86

270

CC

Schubert

120

IL4

N

417

276

CC

Donn

69

IL4

N

86

270

CC

Schubert

120

IL4

N

72

165

CC

Trend in female cases

Suppiah

136

IL4

Y

130

103

CC

Cinek

132

IL4R

N

72

165

CC

Trend in female cases

Suppiah

136

IL4RA

N

130

103

CC

Cinek

132

IL5RA

N

120

500

CC

Epplen

56

IL6

N

417

276

CC

Donn

69

IL6

Y

222

TDT

Only systemic JIA patients studied

Ogilvie

76

IL6

N

86

270

CC

Schubert

120

IL6

N

130

103

CC

Cinek

132

IL8

N

86

270

CC

Schubert

120

IRF1

Y

417

276

CC

Donn

69

IRF1

N

765

508

CC

Fife

140

IRF2

N

120

500

CC

Epplen

56

LMP 7

Y

207

50

CC

Prahalad

141

MBL

N

93

48

CC

Kang

142

MCP1

N

86

270

CC

Schubert

120

MCP1

N

66

150

CC

Ozyurek

143

MEFV

Y

71

100

CC

Included 12 subjects with vasculitis

Ozen

144

MEFV

Y

950

728

CC

Association in psoriatic JIA after correction for multiple testing

Day

145

MHC2TA

Y

74

316

CC

O'Doherty

146

MICA

Y

128

113

CC

Association with A4 allele

Nikitina Zake

147

MIF

Y

526

259

CC

Donn

60

MIF

N

150

390

CC

Miterski

59

MIF

Y

224

341

CC

Association with allele 05

Miterski

59

MIF

Y

321

TDT

Donn

61

MIF

N

86

270

CC

Schubert

120

MIF

N

67

153

CC

Berdeli

62

MTHFR

N

56

62

CC

Huemer

148

MTR

N

56

62

CC

Huemer

148

MTRR

N

56

62

CC

Huemer

148

NLP3

Y

950

728

CC

Association in psoriatic JIA after correction for multiple testing

Day

145

NOD2

N

950

728

CC

Association in psoriatic JIA before correction for multiple testing

Day

145

NOS33

N

86

270

CC

Schubert

120

Osteopontin

N

119

200

CC

Oligo JIA only.

Marciano

149

PAFAH

N

86

270

CC

Schubert

120

PRF1

N

133

384

CC

Only systemic JIA studied

Donn

95

PRL

N

463

276

CC

Donn

123

PSTPIP1

N

950

728

CC

Association in psoriatic JIA before correction for multiple testing

Day

145

PTPN22

Y

661

595

CC

Hinks

84

PTPN22

N

230

1400

CC

Seldin

85

PTPN22

Y

320

555

CC

Viken

86

PTPN22

Y

130

400

CC

Cinek

87

PTPRC

N

161

362

CC

Miterski

59

Rab27a

N

133

384

CC

Only systemic studied

Donn

95

RANTES

N

86

270

CC

Schubert

120

SELP

N

86

270

CC

Schubert

120

SH2D2A

Y

210

558

CC

Smerdel

150

SLC11A1

Y

119

111

CC

Also named NRAMP1

Sanjeevi

66

SLC11A1

Y

234

639

TDT

Runstadler

67

SLC26A2

Y

826

617

CC

Association seen only in systemic jia

Lamb

151

SUMO4

N

668

484

CC

Gibbons

152

TAP

Y

285

165

CC

Despite correcting for HLA

Ploski

153

Tapasin

Y

156

TDT

Only systemic studied

Bukulmez

154

TCRBv6.1

Y

126

207

CC

Association in HLADQA1*0101 positive subjects

Maksymowych

155

TCRBv6.1

N

77

40

CC

only HLADQA1*0101 positive subjects

Ploski

156

TCRBv6.1

N

120

500

CC

Epplen

56

TCRDVAJ

N

120

500

CC

Epplen

56

TEA

N

120

500

CC

Epplen

56

TGFB1

N

130

103

CC

Cinek

132

TLR4

N

313

TDT

Lamb

157

TLR4

N

86

270

CC

Schubert

120

TLR9

N

86

270

CC

Schubert

120

TNFA

Y

128

114

CC

Association with A2 allele

Nikitina Zake

147

TNFA

Y

142

388

CC

Association with allele 6

Miterski

59

TNFA

N

170

415

CC

Miterski

59

TNFA

Y

228

196

CC

Association in psoriatic, RF-negative subtypes

Schmeling

58

TNFA

N

86

270

CC

Schubert

120

TNFA

N

55

68

CC

Difference between oligo and systemic

Modesto

158

TNFA

N

107

630

CC

Cimaz

134

TNFA

Y

120

500

CC

Microsatellite

Epplen

56

TNFB

N

128

114

CC

Nikitina Zake

147

TNFB

N

86

270

CC

Schubert

120

TNFR1

N

132

334

CC

Miterski

59

TNFR2

N

435

261

CC

Zeggini

159

TNFR2

N

146

428

CC

Miterski

59

TRAF1

Y

67

1952

CC

Subjects genotyped as part of genome-wide association

Behrens

160

UNC13D

N

133

384

CC

Only systemic JIA studied

Donn

95

WISP3

Y

159

263

CC

Lamb

77

WISP3

Y

181

355

CC

Replication study

Lamb

77

Marker: Gene or locus studied for association. Assn: Association; CC: case-control; TDT: transmission-disequilibrium testing.

 <p>Table 3</p>

Non-HLA genetic genes associated with JIA that have been independently confirmed.

PTPN22

TNFA

MIF

WISP3

SLC11A1

 <p>Table 4</p>

Sample sizes requirements for genetic association studies

MAF

10%

20%

30%

40%

Cases

controls

Cases

controls

Cases

Controls

Cases

Controls

OR

2.0

223

446

137

274

113

226

107

214

1.5

703

1406

415

830

332

664

304

608

1.3

1751

3502

1016

2032

798

1596

719

1438

Table shows number of cases and controls that need to be typed to detect associations at a significance value of 0.05, power of 80%, for various minor allele frequencies, and odds ratios. A case: control ratio of 1:2 is assumed. OR: odds ratio; MAF: minor allele frequency.

Interpreting the different associations (or lack of associations) between genetic variants and phenotypes can be further complicated by differences in phenotype description. JIA comprises several sub-phenotypes with distinct clinical features and outcomes48. Although the ILAR classification criteria, which are increasingly being used to describe juvenile arthritis attempts to define homogenous subtypes, there are still some challenges. For instance a child with four affected joints is classified as oligoarticular JIA, while a child with five affected joints is classified as polyarticular JIA, although clinically the difference is not significant. Similarly, a child with five affected joints and another with over 20 joints are both classified as polyarticular, although clinically they appear distinct. While this can be addressed in part, by analyzing children with JIA as a group, and then performing analyses by subtypes, this results in multiple comparisons. One approach to address this issue might be to use genetic information to stratify subjects into subtypes, and this might results in more homogenous subtypes. For instance studies of adult RA subjects frequently stratify the subjects based on presence or absence of the shared HLA-DR epitope4950. Similarly, it might be reasonable to stratify JIA patients by HLA associations while conducting genetic studies. It also would better facilitate comparisons of genetic studies performed in different populations. Finally, this would also help to delineate associations due to LD. For instance the MHC region has extensive LD, and associations described with variants in this region could be due to LD with HLA polymorphisms. Together, these observations reinforce the need for meticulous attention to defining the phenotypes and caution with interpreting results of genetic association studies.

A recent critical review of several genes and polymorphisms tested as part of commercially available genomic profiles highlights the challenges of genetic association testing 51. The authors used individual gene-disease association studies as well as meta-analyses to examine polymorphisms in 56 genes. Of these 32 genes had been examined in meta-analyses of 160 polymorphism-disease association comparisons. Only 38% were found to be statistically significant, with very modest associations. Furthermore, often associations were found with phenotypes different from the original phenotype being tested for association. For instance, genes tested in cardiogenomic profiles were more frequently associated with non-cardiac diseases. It is anticipated that most disease-phenotype associations of complex traits are likely to be of modest significance, with OR <1.5 52. Thus, the modest genetic effects necessitates collaboration, both by performing collaborative studies where samples are pooled, as well as by data-sharing by investigators in order to detect meaningful associations53.

Non-replication of initial associations can be due to myriad factors including a false-positive result in the first cohort, population stratification in the first cohort, inadequate power in the replication cohort(s), genotyping errors, selection biases, and true population differences. It should be noted that lack of an association in the first cohort often might discourage further studies of that gene by other investigators, even though the first cohort might not have had adequate power to truly detect a modest association. The power to detect associations also depends on the minor allele frequency, and hence for rare variants much larger samples would be necessary. It is feasible to increase the power of genetic studies by using large numbers of appropriate controls, thereby increasing the control to case ratio. The quality of genetic associations will be significantly enhanced by increasing sample sizes, and validating initial discoveries by collaborative studies. Following published guidelines for performing and reporting genetic association studies will improve the quality of studies and facilitate the discovery of true causal variants5455. For instance, providing power calculations, and if the variant under study has been investigated previously, performance of a meta-analysis would be beneficial. Ultimately, associations that are reproducible, as well as demonstration of functional consequences of genetic variation are necessary to translate the results of these studies to the diagnosis, treatment and understanding of JIA.

Association studies between JIA and non-HLA variants have been reviewed previously 333435. The following are some genetic associations that have been confirmed in more than one cohort. TNFA, the gene encoding the pro-inflammatory cytokine TNF-α has been the focus of several association studies of autoimmune diseases. Associations between TNFA and different JIA subtypes have been previously reported. An association between early onset oligoarticular JIA and TNF variants were reported by Epplen et al56. Another study found associations between persistent oligoarticular JIA and TNFA variants57. An association between a SNP at position -857 of TNFA and sJIA was reported by Date et al45. Schmeling et al found an association between TNFA variants and psoriatic arthritis polyarticular JIA subtypes58. In a case control study of children with JIA, Miterski et al found no associations with TNFA SNPs, but found an association with a microsatellite in the TNFA gene59. Thus, while variants in TNFA appear to be associated with JIA, there are clearly differences between various studies with regard to the associated variant(s) and/or associated subtype. It should be noted that some of the associations could be due to LD, as the TNFA and HLA loci are both contained in the MHC region.

The gene encoding macrophage migration inhibitory factor (MIF) has also been investigated in several cohorts of patients with JIA. A functional SNP at position -173 has been associated with JIA in the study by Donn et al, in 526 British children with JIA and 259 ethnicity-matched controls60. This finding was replicated using an independent cohort of JIA trios, using TDT 61. However, this SNP did not show an association in the studies by Miterski et al, and Berdeli et al, although it should be noted that both of these cohorts had smaller number of subjects 5962. Of interest, the latter study did find that carriage of -173C allele was a strong predictor of poor outcome of JIA62. It has previously been shown that this allele is a predictor of poor outcome in sJIA 63. A recent study of patients with oligoarticular JIA that had been followed for at least 5 years confirmed that -173C was a predictor of poor response to intra-articular corticosteroid treatment 64. Together, these studies imply that MIF variants may be associated with susceptibility to JIA, as well as the phenotype of JIA but should be noted that MIF-173C was not associated with adult RA in a replication study65.

The SLC11A1 gene (formerly called NRAMP1) is important in natural resistance to various intracellular infections mediated by macrophages. Variants in this gene have also been found to be associated with JIA in at least two cohorts 6667. In the first study of Latvian and Russian children with JIA, a functional promoter microsatellite polymorphism (allele 3) was found to be associated with susceptibility to JIA (OR 2.26)66. Conversely, another variant, allele 2, was associated with protection from JIA. Interestingly, these alleles demonstrate opposite associations in infection and autoimmunity, with allele 3 conferring susceptibility to autoimmunity and protection from tuberculosis. Conversely, allele 2 confers protection from autoimmunity while increasing susceptibility to tuberculosis. These suggest that balancing natural selection might be acting upon this locus. In a subsequent study, Runstadler et al studied both of these SLC11A1 alleles as well as three SNPs and an insertion/deletion polymorphism in the region 67. A six-marker haplotype demonstrated a strong association with JIA as a group, as well as in oligoarticular and polyarticular subtypes. Haplotypes that did not contain allele 3 identified in the study by Sanjeevi et al, were also found to show significant association suggesting that variants in this region might have independent associations with JIA. These two studies support a role for SLC11A1 variants in JIA susceptibility.

The gene encoding IL-1α, a potent pro-inflammatory cytokine, has been investigated in several JIA cohorts for a genetic association. Originally an association was described between a SNP in the promoter region of IL1A in Norwegian children with JIA68. The association was most pronounced in those with early onset oligoarticular JIA. However this finding was not replicated in two cohorts from the UK in subsequent studies, although one study investigating a number of polymorphisms demonstrated an association that was not significant when corrected for multiple comparisons 6970. A recent two-staged association study identified several variants in the IL-1 gene cluster, and some in the IL-1 receptor cluster were associated with systemic JIA 71. IL-6 is another potently pro-inflammatory cytokine shown to be elevated in children with JIA16727374. A functional SNP in the promoter of the IL6 gene was shown to be associated with sJIA by Fishman et al. The effect was pronounced in children under 5 years of age75. This finding was not replicated in a smaller sJIA cohort by Donn et al69. However, using an international cohort of families of children with sJIA, Ogilvie et al did find a significant association between the IL6-174 SNP and sJIA, but in children with onset >5 years76. An association between a promoter variant in IRF1, the gene encoding interferon regulatory factor and JIA was reported by Donn et al in a cohort of 417 cases with JIA and 276 controls69. However, when they repeated the study using different controls and additional cases, no significant differences in allele or genotype frequencies of several IRF1 variants were observed. Together, these studies illustrate the difficulties of replicating significant positive findings from initial cohorts in subsequent larger replication studies.

An association between a SNP (G84A) in the gene encoding the Wnt-1 inducible signaling pathway protein 3 (WISP3) and polyarticular JIA was described by Lamb et al77. After observing a positive association in the initial cohort of 159 cases and 263 controls, the finding was replicated in an independent cohort of 181 cases and 355 controls. In addition they used parent-child trios for TDT, which demonstrated a trend towards over-transmission of the 84A allele. This finding has not been replicated in other cohorts to our knowledge.

JIA and RA are examples of autoimmune diseases mediated by Th1-immune responses. Synovial T-cells express high levels of the Th1-chemokine receptor (CCR5). A 32 basepair deletion in the open reading frame of the gene encoding CCR5 (Δ32) has been shown to be protective against RA in a meta-analysis of RA association studies78. We have shown that a variant in the promoter region of CCR5, C-1835T is significantly under-transmitted to children with early onset JIA, and with oligoarticular JIA79. CCR5-Δ32 was also tested in ~700 simplex and multiplex JIA families and found to be under-transmitted to children with early onset JIA. These two variants did not appear to be in LD, and the haplotype that did not contain either of the "protective" variants was significantly over-transmitted. In a study of Norwegian adults with RA and children with JIA, Lindner et al tested CCR5-Δ32, and failed to replicate these results80. When they repeated the meta-analysis of RA association studies including their results, the negative association between RA and CCR5-Δ32 was less pronounced, but still statistically significant (OR 0.8, p < 0.007). When they compared children with JIA and the controls, although there was a trend towards a negative association, it was not statistically significant (OR 0.82, p < 0.15). The authors in that study did not investigate other CCR5 variants, including C-1835T.

The gene PTPN22 encodes a lymphoid tyrosine phosphatase (LYP) involved in inhibition of T-cell activation. A SNP within the PTPN22 gene (C1858T) has been shown to be associated with multiple autoimmune phenotypes including RA, T1DM, and SLE65818283. To date, there have been four studies of this polymorphism in JIA cohorts 848586. The study by Seldin et al did not find an association between 230 Finnish probands with JIA and this PTPN22 variant85. In contrast, Viken et al reported an association between JIA and PTPN22 C1858T using 320 Norwegian cases86. Another study by Hinks et al also confirmed an association between PTPN22 and JIA using 661 JIA cases from the UK84. A fourth study using Czech JIA patients also confirmed the association between the C1858T variant and JIA87. A pooled analysis of these four studies confirms that carriage of the T allele increases the susceptibility to JIA, although the magnitude of the association is only modest, with an OR of ~1.3. Thus, PTPN22 has been shown to have an association with JIA.

Strategies to select candidate genes

Selection of candidate genes to be tested for association with JIA might be aided by careful definition of the phenotype, and by testing variants predisposing to monogenic diseases that share phenotypic features with JIA subtypes. For instance, macrophage activation syndrome (MAS), a potentially life-threatening complication, can occur in children with sJIA 88. MAS is characterized by an overwhelming inflammatory reaction, and is phenotypically similar to hemophagocytic lymphohistiocytosis (HLH). Both familial and acquired forms of HLH are observed. Four autosomal recessive forms of familial HLH have been described, and three of these have been linked to mutations in the genes encoding perforin (PRF1), Munc13-14 (UNC13D), and syntaxin 11 (STX11)89. The products encoded by these genes are involved in controlling granule exocytosis in cytotoxic lymphocytes, which are necessary for the physiologic termination of certain immune responses.

Investigations of natural killer (NK) and cytotoxic functions in children with sJIA and MAS have revealed evidence of decreased NK cell activity similar to that seen in familial HLH 90. In an investigation of NK cell dysfunction, children with sJIA demonstrated significantly decreased NK cell activity compared to pediatric controls, while decreased NK cell activity was rare in children with other JIA subtypes91. Grom et al, described three children with sJIA and MAS who demonstrated low levels of perforin expression in all cytotoxic cell populations indistinguishable from that in carriers of perforin-deficient familial HLH90. These children did not have PRF1 mutations. In a larger study, 62 children with sJIA (some with MAS) were screened for PRF1 mutations92. Four mutations were identified, out of which, one (Ala91Val) was significantly higher in children who had MAS and sJIA. In a recent study, Zhang et al investigated whether variants in UNC13D contribute to MAS in 18 subjects with MAS and sJIA93. None of the 18 had mutations in PRF1. Two had mutations consistent with a diagnosis of familial HLH. Nine of the remaining 16 had a unique haplotype of 12 SNPs, which was significantly greater than that in controls, (57% vs. 12 %, P < 0.000001), suggesting that this UNC13D haplotype is associated with MAS. The frequency of this haplotype in 73 children with sJIA who did not have MAS was not significantly different compared to controls.

Recently, Hazen et al reported on an 8 year old girl with sJIA without clinical evidence of MAS, who carried compound heterozygote mutations in the UNC13D gene, and reduced NK cell cytotoxic function89. This suggests that some children with sJIA without clinical evidence of MAS have abnormal NK cell function. To estimate the frequency of occult MAS, Behrens et al studied 15 children with sJIA that underwent bone marrow aspirations 94. Occult MAS was found in 8 subjects, although only 2 had clinical evidence of MAS, suggesting that the immune dysregulation seen in MAS might be integral to the pathogenesis of sJIA. Thus, MAS/HLH could be a part of the spectrum of sJIA, and therefore, it is plausible that genetic variants predisposing to familial HLH might also play a role in susceptibility to MAS, and/or sJIA. Recently, variants in PRF1, GZMB, UNC13D and Rab27a genes were tested for association with sJIA using 133 cases and 384 controls 95. None of the variants demonstrated an association with sJIA. Together, these illustrate that careful genotype-phenotype correlations, and extending associations from related phenotypes, will improve the odds of detecting variants predisposing to susceptibility to JIA and its subtypes.

Genome-wide studies

Another approach to finding genes underlying complex traits is to search the entire genome to find genetic markers that are present more often in affected individuals. Large extended multiplex pedigrees are relatively rare precluding conventional parametric linkage studies, in which parameters such as genetic model, mode of inheritance, penetrance of each genotype etc need to be specified. These parameters are often not available for many complex diseases. An alternative approach is to use non-parametric methods of linkage such as allele-sharing methods in affected sibling pairs. Thompson et al performed a genome wide linkage study using ~400 microsatellite polymorphisms in 121 JIA affected sibling pair families 96. Although this study confirmed the role of HLA and identified several other regions of interest, the study had limited power and a replication cohort was not available. The heterogeneity of JIA further results in lower power when subjects are stratified by different JIA subtypes. The strongest evidence of linkage to JIA was near the HLA-DRB1 locus. When subjects were stratified by JIA subtype evidence for linkage was found at different chromosomal locations for early onset oligoarticular JIA and polyarticular JIA. This suggests that while some loci such as HLA contribute to JIA susceptibility in general, there are likely other loci that influence the different JIA subtypes. This familiar linkage approach is now being superseded by association studies that involve the entire genome.

An attractive alternative approach to linkage studies is to perform a genome-wide association study (GWAS), which does not require multiplex families, but can be performed with large number of cases and controls. A GWAS examines tens of thousands of genetic variants in a large number of unrelated cases and controls. GWAS have led to the successful identification of several genetic variants that underlie complex autoimmune phenotypes including T1DM, RA, IBD, AS 979899100101. A large collaborative GWAS utilized 3000 shared controls and 2000 cases of 7 different common complex traits which included IBD, RA and T1DM99. In all, 17000 individuals were genotyped for >500,000 SNPs. This study confirmed previously reported associations such as IL23R, and NOD2 for IBD, HLA-DRB1 and PTPN22 for RA and T1DM as well as several other loci for T1DM99. In addition this study identified several new loci that showed strong evidence of association with IBD, RA and T1DM. Some SNPs appear to be associated with more than one autoimmune disease. Other investigators have used GWAS to identify other loci underlying RA such as TRAF1/C5102. Interestingly another group using a candidate gene approach also reported an association between RA and TRAF1/C5 locus 103. GWAS have also been successful in identifying other RA associated loci. Two groups reported associations between individuals with RA and variants located on 6q23, near which are some possible candidate genes102104. Together these studies demonstrate the feasibility of performing GWAS to identify genes underlying predisposition to well defined phenotypes.

To date there are no published studies of GWAS in JIA cohorts although several groups are undertaking such studies. Several GWAS studies are in progress in JIA using high density SNP platforms. Data published in abstract forms suggest that this approach might be successful in identifying JIA associated variants. In a GWAS utilizing individuals with JIA and RA using a SNP platform with 115,075 SNPs, John et al were able to detect known susceptibility loci such as PTPN22 and HLA 105. Using a high density SNP GWAS, Thompson et al were able to identify specific polymorphisms potentially involved in JIA at large, as well as other SNPs that appear to influence specific JIA subtypes 106. Confirmation of initial discoveries from these studies in in independent cohorts is necessary. The consolidation of available cohorts is an active need to improve power, as well as to enable replication studies.

Genetic variables underlying autoimmunity in general

It has increasingly become clear that autoimmune diseases can cluster both in individuals, as well as in families107. We have shown previously, using a case-control design that relatives of patients with JIA have increased prevalence of several autoimmune diseases, especially autoimmune thyroid disease 26. Others have found increased prevalence of autoimmune thyroid disease or celiac disease in patients with JIA 108109110. Prevalence of T1DM is also increased in children with JIA23111. Together these studies suggest that clinically distinct autoimmune phenotypes cluster in individuals and families. This supports the hypothesis that common genetic factors might predispose to clinically distinct autoimmune phenotypes.

There are now several concrete examples of genetic variants that influence susceptibility to multiple clinically distinct autoimmune disorders. For instance, a SNP in the CTLA4 gene, CT60, has been found to be associated with autoimmune thyroiditis, and T1DM112. The same variant has been found to be associated with RA in a meta-analyses 65. However, this SNP does not appear to play a major role in susceptibility to RF-negative RA or JIA65113. A PTPN22 variant has also been associated with multiple autoimmune diseases including RA, SLE, T1DM and JIA. Similarly there are other genetic variants that are associated with multiple autoimmune diseases (Table 5). For instance variants in TNFA appear to be associated with RA, JIA, and SLE. Variants in CCR5 appear to be protective against both RA and JIA 7879114. Similarly, IL23R variants seems to be associated with IBD, Psoriasis and AS, but not with RA 97101115116117. Together, these examples suggest that genetic variants which underlie susceptibility to other autoimmune phenotypes could also potentially be involved in JIA susceptibility. This hypothesis was tested by Thomson et al, who tested IL2RA variants associated with both RA and T1DM in children with JIA118. IL2RA variants were also associated with JIA. These results suggest that investigating genetic variants demonstrating association with multiple autoimmune phenotypes in JIA cohorts might be an attractive approach to find JIA susceptibility genes.

<p>Table 5</p>

Examples of genes associated with multiple autoimmune diseases:

Gene

Autoimmune diseases associated

CTLA4

RA, AITD, SLE, T1DM, MS, Celiac disease, autoimmune hepatitis

PTPN22

RA, SLE, T1DM, JIA, Vitiligo, Wegener's, AITD

PDCD1

SLE, RA, T1DM

TNFA

RA, JIA, Crohn's disease

SLC11A1

Crohn's, JIA, RA, T1DM

IL-6

JIA, T1DM, SLE

IL-1A

JIA, RA

MIF

Alopecia areata, JIA, RA, Ulcerative colitis

STAT4

RA, SLE

IL-2RA

T1DM, RA, JIA

CCR5

JIA, RA, MS, T1DM

IL23R

Crohn's disease, Psoriasis, spondyloarthropathy

RA: Rheumatoid arthritis, AITD: autoimmune thyroid disease, SLE: systemic lupus erythematosus, T1DM: type 1 diabetes mellitus, MS: multiple sclerosis, JIA: juvenile idiopathic arthritis,.

In summary, JIA appears to be influenced by genetic factors, both within and outside the HLA region. While many of the HLA associations have been replicated in independent cohorts, only a few of the non-HLA associations have been replicated. The major reason for non-replication appears to be insufficient power. Advances such as genome-wide association studies and collaborative efforts are likely to result in the discovery of new genetic associations, as well as validate (or refute) some of the previously described associations. Finally understanding how a genetic variant associated with JIA and/or other autoimmune diseases influences disease susceptibility is essential to translating findings from the lab to the care of children with JIA.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SP is the primary author, conceived the article, performed a systematic review of the literature, synthesized the results and wrote the article. DNG is the corresponding author, made substantial contribution to the conception and design of the article, and was involved in revising the manuscript. Both authors read and approved the final manuscript.

Acknowledgements

Supported by, The National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23-AR50177, N01-AR42272, P01 AR048929), The National Institute of Allergy and Infectious Disease (U01 UA1067150A), The National Center for Research Resources (RR00064), The Arthritis Foundation, and The Val A Browning Charitable Foundation, and The Primary Children's Medical Center Foundation, Salt Lake City, UT.

 <p>Juvenile idiopathic arthritis</p> Ravelli A Martini A Lancet 2007 369 9563 767 778 10.1016/S0140-6736(07)60363-8 17336654 <p>International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001</p> Petty RE Southwood TR Manners P Baum J Glass DN Goldenberg J He X Maldonado-Cocco J Orozco-Alcala J Prieur AM Suarez-Almazor ME Woo P J Rheumatol 2004 31 2 390 392 14760812 <p>Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?</p> Prahalad S Glass DN Arthritis Res 2002 4 303 310 10.1186/ar594 <p>Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue</p> Silverman ED Isacovics B Petsche D Laxer RM Clin Exp Immunol 1993 91 1 90 95 1554635 8093436 <p>The value of biopsy in patients with monarticular juvenile rheumatoid arthritis of recent onset</p> Konttinen YT Bergroth V Kunnamo I Haapasaari J Arthritis Rheum 1986 29 1 47 53 10.1002/art.1780290107 3511921 <p>Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction</p> Forre O Dobloug JH Natvig JB Scand J Immunol 1982 15 2 227 231 10.1111/j.1365-3083.1982.tb00643.x 6213027 <p>Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis</p> Wedderburn LR Robinson N Patel A Varsani H Woo P Arthritis Rheum 2000 43 4 765 774 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B 10765921 <p>Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis</p> Wedderburn LR Woo P Springer Semin Immunopathol 1999 21 3 361 374 10666778 <p>Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios</p> Thompson SD Luyrink LK Graham TB Tsoras M Ryan M Passo MH Glass DN J Immunol 2001 166 11 6899 6906 11359851 <p>Th1 and Th2 in human diseases</p> Romagnani S Clin Immunol Immunopathol 1996 80 3 Pt 1 225 235 10.1006/clin.1996.0118 8811042 <p>T cells involved in psoriasis vulgaris belong to the Th1 subset</p> Schlaak JF Buslau M Jochum W Hermann E Girndt M Gallati H Meyer zum Buschenfelde KH Fleischer B The Journal of investigative dermatology 1994 102 2 145 149 10.1111/1523-1747.ep12371752 8106745 <p>Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis</p> Eberhard BA Laxer RM Andersson U Silverman ED Clin Exp Immunol 1994 96 2 260 266 1534897 8187333 <p>Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease</p> Murray KJ Grom AA Thompson SD Lieuwen D Passo MH Glass DN J Rheumatol 1998 25 7 1388 1398 9676774 <p>Identification of Th subsets in juvenile rheumatoid arthritis confirmed by intracellular cytokine staining</p> Ozen S Tucker LB Miller LC J Rheumatol 1998 25 8 1651 1653 9712118 <p>Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype</p> Gattorno M Facchetti P Ghiotto F Vignola S Buoncompagni A Prigione I Picco P Pistoia V Clin Exp Immunol 1997 109 1 4 11 1904718 9218817 10.1046/j.1365-2249.1997.4331330.x <p>Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis</p> Prahalad S Martins TB Tebo AE Whiting A Clifford B Zeft AS McNally B Bohnsack JF Hill HR Pediatric rheumatology online journal 2008 6 1 8 2430568 18507862 10.1186/1546-0096-6-8 <p>Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis</p> Jarvis JN Petty HR Tang Y Frank MB Tessier PA Dozmorov I Jiang K Kindzelski A Chen Y Cadwell C Turner M Szodoray P McGhee JL Centola M Arthritis Res Ther 2006 8 5 R154 1779452 17002793 10.1186/ar2048 <p>Genetic analysis of juvenile rheumatoid arthritis: approaches to complex traits</p> Prahalad S Curr Probl Pediatr Adolesc Health Care 2006 36 3 83 90 10.1016/j.cppeds.2005.10.009 16473284 <p>Twins concordant for juvenile rheumatoid arthritis</p> Prahalad S Ryan MH Shear ES Thompson SD Glass DN Giannini EH Arthritis Rheum 2000 43 11 2611 2612 10.1002/1529-0131(200011)43:11<2611::AID-ANR33>3.0.CO;2-T 11083290 <p>Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance</p> Moroldo MB Chaudhari M Shear E Thompson SD Glass DN Giannini EH Arthritis Rheum 2004 50 6 1928 1934 10.1002/art.20292 15188369 <p>Juvenile rheumatoid arthritis in affected sibpairs</p> Moroldo MB Tague BL Shear ES Glass DN Giannini EH Arthritis Rheum 1997 40 11 1962 1966 10.1002/art.1780401107 9365084 <p>Juvenile rheumatoid arthritis as a complex genetic trait</p> Glass DN Giannini EH Arthritis Rheum 1999 42 11 2261 2268 10.1002/1529-0131(199911)42:11<2261::AID-ANR1>3.0.CO;2-P 10555018 <p>Familial aggregation of juvenile idiopathic arthritis</p> Prahalad S O'Brien E Fraser AM Kerber RA Mineau GP Pratt D Donaldson D Bamshad MJ Bohnsack J Arthritis Rheum 2004 50 12 4022 4027 10.1002/art.20677 15593218 <p>Genetic dissection of complex traits [published erratum appears in Science 1994 Oct 21;266(5184):353]</p> Lander ES Schork NJ Science 1994 265 5181 2037 2048 10.1126/science.8091226 8091226 <p>Genetics of complex disease: approaches, problems, and solutions</p> Schork NJ Am J Respir Crit Care Med 1997 156 4 Pt 2 S103 9 9351588 <p>Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis</p> Prahalad S Shear ES Thompson SD Giannini EH Glass DN Arthritis Rheum 2002 46 7 1851 1856 10.1002/art.10370 12124869 <p>Familial autoimmunity: maternal parent-of-origin effect in juvenile idiopathic arthritis</p> Zeft A Shear ES Thompson SD Glass DN Prahalad S Clin Rheumatol 2007 17994193 <p>Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs</p> Prahalad S Ryan MH Shear ES Thompson SD Giannini EH Glass DN Arthritis Rheum 2000 43 10 2335 2338 10.1002/1529-0131(200010)43:10<2335::AID-ANR22>3.0.CO;2-W 11037894 <p>A haplotype map of the human genome</p> Nature 2005 437 7063 1299 1320 1880871 16255080 10.1038/nature04226 <p>Association study designs for complex diseases</p> Cardon LR Bell JI Nat Rev Genet 2001 2 2 91 99 10.1038/35052543 11253062 <p>Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations</p> Tabor HK Risch NJ Myers RM Nat Rev Genet 2002 3 5 391 397 10.1038/nrg796 11988764 <p>Linkage disequilibrium and the search for complex disease genes</p> Jorde LB Genome Res 2000 10 10 1435 1444 10.1101/gr.144500 11042143 <p>Susceptibility to JRA/JIA: complementing general autoimmune and arthritis traits</p> Phelan JD Thompson SD Glass DN Genes Immun 2006 7 1 1 10 10.1038/sj.gene.6364273 16435022 <p>Genetics of juvenile idiopathic arthritis: an update</p> Prahalad S Curr Opin Rheumatol 2004 16 5 588 594 10.1097/01.bor.0000134407.48586.b0 15314499 <p>Non-HLA gene polymorphisms in juvenile rheumatoid arthritis</p> Rosen P Thompson S Glass D Clin Exp Rheumatol 2003 21 5 650 656 14611119 <p>Genetic epidemiology of juvenile idiopathic arthritis</p> Forre O Smerdel A Scand J Rheumatol 2002 31 3 123 128 10.1080/713798345 12195624 <p>Juvenile idiopathic arthritis genetics - what's new? What's next?</p> Thomson W Donn R Arthritis Res 2002 4 5 302 306 128941 12223104 10.1186/ar591 <p>Class I associations and frequencies of class II HLA-DRB alleles by RFLP analysis in children with rheumatoid-factor-negative juvenile chronic arthritis</p> Brunner HI Ivaskova E Haas JP Andreas A Keller E Hoza J Havelka S Scholz S Sierp G Albert ED Rheumatol Int 1993 13 2 83 88 10.1007/BF00307739 8102807 <p>Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles</p> Murray KJ Moroldo MB Donnelly P Prahalad S Passo MH Giannini EH Glass DN Arthritis Rheum 1999 42 9 1843 1853 10.1002/1529-0131(199909)42:9<1843::AID-ANR8>3.0.CO;2-M 10513798 <p>Increased prevalence of W27 in juvenile rheumatoid arthritis</p> Rachelefsky GS Terasaki PI Katz R Stiehm ER N Engl J Med 1974 290 16 892 893 4544652 <p>Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients</p> Thomson W Barrett JH Donn R Pepper L Kennedy LJ Ollier WE Silman AJ Woo P Southwood T Rheumatology (Oxford) 2002 41 10 1183 1189 10.1093/rheumatology/41.10.1183 12364641 <p>HLA antigens in juvenile arthritis. Genetic basis for the different subtypes</p> Forre O Dobloug JH Hoyeraal HM Thorsby E Arthritis Rheum 1983 26 1 35 38 10.1002/art.1780260106 6401993 <p>Transmission disequilibrium as a test of linkage and association between HLA alleles and pauciarticular-onset juvenile rheumatoid arthritis</p> Moroldo MB Donnelly P Saunders J Glass DN Giannini EH Arthritis Rheum 1998 41 9 1620 1624 10.1002/1529-0131(199809)41:9<1620::AID-ART12>3.0.CO;2-L 9751094 <p>HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease</p> Ploski R Vinje O Ronningen KS Spurkland A Sorskaar D Vartdal F Forre O Arthritis Rheum 1993 36 4 465 472 10.1002/art.1780360406 8457222 <p>Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes</p> Date Y Seki N Kamizono S Higuchi T Hirata T Miyata K Ohkuni M Tatsuzawa O Yokota S Joo K Ueda K Sasazuki T Kimura A Itoh K Kato H Arthritis Rheum 1999 42 12 2577 2582 10.1002/1529-0131(199912)42:12<2577::AID-ANR10>3.0.CO;2-O 10616003 <p>Pathogenesis of juvenile chronic arthritis: genetic and environmental factors</p> Murray K Thompson SD Glass DN Archives of disease in childhood 1997 77 6 530 534 1717420 9496193 <p>Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis</p> Veit TD Vianna P Scheibel I Brenol C Brenol JC Xavier RM Delgado-Canedo A Gutierrez JE Brandalize AP Schuler-Faccini L Chies JA Tissue Antigens 2008 71 5 440 446 10.1111/j.1399-0039.2008.01019.x 18331529 <p>Subtype-specific outcomes in juvenile idiopathic arthritis: a systematic review</p> Prahalad S Current Medical Literature: Rheumatology 2006 25 1 1 9 <p>Investigation of association between the TRAF family genes and RA susceptibility</p> Potter C Eyre S Cope A Worthington J Barton A Ann Rheum Dis 2007 66 10 1322 1326 10.1136/ard.2006.065706 17277003 <p>Association between ss2-adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with HLA-DRB1 shared epitope</p> Malysheva O Pierer M Wagner U Wahle M Wagner U Baerwald C Ann Rheum Dis 2008 18267980 <p>A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions</p> Janssens AC Gwinn M Bradley LA Oostra BA van Duijn CM Khoury MJ Am J Hum Genet 2008 82 3 593 599 10.1016/j.ajhg.2007.12.020 18319070 <p>On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies</p> Khoury MJ Little J Gwinn M Ioannidis JP International journal of epidemiology 2007 36 2 439 445 10.1093/ije/dyl253 17182636 <p>Commentary: rare alleles, modest genetic effects and the need for collaboration</p> Campbell H Manolio T International journal of epidemiology 2007 36 2 445 448 10.1093/ije/dym055 17470492 <p>Replicating genotype-phenotype associations</p> Chanock SJ Manolio T Boehnke M Boerwinkle E Hunter DJ Thomas G Hirschhorn JN Abecasis G Altshuler D Bailey-Wilson JE Brooks LD Cardon LR Daly M Donnelly P Fraumeni JF Jr. Freimer NB Gerhard DS Gunter C Guttmacher AE Guyer MS Harris EL Hoh J Hoover R Kong CA Merikangas KR Morton CC Palmer LJ Phimister EG Rice JP Roberts J Rotimi C Tucker MA Vogan KJ Wacholder S Wijsman EM Winn DM Collins FS Nature 2007 447 7145 655 660 10.1038/447655a 17554299 <p>Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations</p> Little J Bradley L Bray MS Clyne M Dorman J Ellsworth DL Hanson J Khoury M Lau J O'Brien TR Rothman N Stroup D Taioli E Thomas D Vainio H Wacholder S Weinberg C Am J Epidemiol 2002 156 4 300 310 12181099 <p>Immunoprinting excludes many potential susceptibility genes as predisposing to early onset pauciarticular juvenile chronic arthritis except HLA class II and TNF</p> Epplen C Rumpf H Albert E Haas P Truckenbrodt H Epplen JT Eur J Immunogenet 1995 22 4 311 322 10.1111/j.1744-313X.1995.tb00247.x 7495783 <p>Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis</p> Zeggini E Thomson W Kwiatkowski D Richardson A Ollier W Donn R Arthritis Rheum 2002 46 12 3304 3311 10.1002/art.10698 12483736 <p>Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis</p> Schmeling H Wagner U Peterson A Horneff G Clin Exp Rheumatol 2006 24 1 103 108 16539828 <p>Complex genetic predisposition in adult and juvenile rheumatoid arthritis</p> Miterski B Drynda S Boschow G Klein W Oppermann J Kekow J Epplen JT BMC genetics 2004 5 1 2 356909 15018649 10.1186/1471-2156-5-2 <p>Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis</p> Donn R Alourfi Z De Benedetti F Meazza C Zeggini E Lunt M Stevens A Shelley E Lamb R Ollier WE Thomson W Ray D Arthritis Rheum 2002 46 9 2402 2409 10.1002/art.10492 12355488 <p>A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis</p> Donn R Alourfi Z Zeggini E Lamb R Jury F Lunt M Meazza C De Benedetti F Thomson W Ray D Arthritis Rheum 2004 50 5 1604 1610 10.1002/art.20178 15146431 <p>Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis</p> Berdeli A Ozyurek AR Ulger Z Gurses D Levent E Salar K Gurpinar AR Rheumatol Int 2006 26 8 726 731 10.1007/s00296-005-0062-7 16220288 <p>Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis</p> De Benedetti F Meazza C Vivarelli M Rossi F Pistorio A Lamb R Lunt M Thomson W Ravelli A Donn R Martini A Arthritis Rheum 2003 48 5 1398 1407 10.1002/art.10882 12746913 <p>Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids</p> Vivarelli M D'Urbano LE Insalaco A Lunt M Jury F Tozzi AE Ravelli A Martini A Donn R De Benedetti F Clin Exp Rheumatol 2007 25 5 775 781 18078632 <p>Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4</p> Plenge RM Padyukov L Remmers EF Purcell S Lee AT Karlson EW Wolfe F Kastner DL Alfredsson L Altshuler D Gregersen PK Klareskog L Rioux JD Am J Hum Genet 2005 77 6 1044 1060 1285162 16380915 10.1086/498651 <p>Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis</p> Sanjeevi CB Miller EN Dabadghao P Rumba I Shtauvere A Denisova A Clayton D Blackwell JM Arthritis Rheum 2000 43 6 1397 1404 10.1002/1529-0131(200006)43:6<1397::AID-ANR25>3.0.CO;2-6 10857800 <p>Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor-negative juvenile idiopathic arthritis in Finnish patients: haplotype analysis in Finnish families</p> Runstadler JA Saila H Savolainen A Leirisalo-Repo M Aho K Tuomilehto-Wolf E Tuomilehto J Seldin MF Arthritis Rheum 2005 52 1 247 256 10.1002/art.20772 15641099 <p>A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism</p> McDowell TL Symons JA Ploski R Forre O Duff GW Arthritis Rheum 1995 38 2 221 228 10.1002/art.1780380210 7848312 <p>Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Paediatric Rheumatology Study Group</p> Donn RP Barrett JH Farhan A Stopford A Pepper L Shelley E Davies N Ollier WE Thomson W Arthritis Rheum 2001 44 4 802 810 10.1002/1529-0131(200104)44:4<802::AID-ANR136>3.0.CO;2-G 11315919 <p>Absence of association between interleukin 1 alpha and oligoarticular juvenile chronic arthritis in UK patients</p> Donn RP Farhan AJ Barrett JH Thomson W Worthington J Ollier WE Rheumatology (Oxford) 1999 38 2 171 175 10.1093/rheumatology/38.2.171 10342632 <p>Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis</p> Stock CJ Ogilvie EM Samuel JM Fife M Lewis CM Woo P Genes Immun 2008 9 4 349 357 10.1038/gene.2008.24 18418395 <p>Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis</p> Lepore L Pennesi M Saletta S Perticarari S Presani G Prodan M Clin Exp Rheumatol 1994 12 5 561 565 7531125 <p>Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis</p> Madson KL Moore TL Lawrence JM 3rd Osborn TG J Rheumatol 1994 21 12 2359 2363 7699643 <p>Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis</p> De Benedetti F Robbioni P Massa M Viola S Albani S Martini A Clin Exp Rheumatol 1992 10 5 493 498 1458703 <p>The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis</p> Fishman D Faulds G Jeffery R Mohamed-Ali V Yudkin JS Humphries S Woo P J Clin Invest 1998 102 7 1369 1376 508984 9769329 10.1172/JCI2629 <p>The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families</p> Ogilvie EM Fife MS Thompson SD Twine N Tsoras M Moroldo M Fisher SA Lewis CM Prieur AM Glass DN Woo P Arthritis Rheum 2003 48 11 3202 3206 10.1002/art.11300 14613283 <p>Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis</p> Lamb R Thomson W Ogilvie E Donn R Arthritis Rheum 2005 52 11 3548 3553 10.1002/art.21392 16255026 <p>Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis</p> Prahalad S Genes Immun 2006 7 3 264 268 10.1038/sj.gene.6364298 16541097 <p>Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis</p> Prahalad S Bohnsack JF Jorde LB Whiting A Clifford B Dunn D Weiss R Moroldo M Thompson SD Glass DN Bamshad MJ Genes Immun 2006 7 6 468 475 10.1038/sj.gene.6364317 16775617 <p>Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis</p> Lindner E Nordang GB Melum E Flato B Selvaag AM Thorsby E Kvien TK Forre OT Lie BA BMC Med Genet 2007 8 33 1906748 17565662 10.1186/1471-2350-8-33 <p>The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis</p> Lee YH Rho YH Choi SJ Ji JD Song GG Nath SK Harley JB Rheumatology (Oxford) 2007 46 49 56 16760194 10.1093/rheumatology/kel170 <p>A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis</p> Begovich AB Carlton VE Honigberg LA Schrodi SJ Chokkalingam AP Alexander HC Ardlie KG Huang Q Smith AM Spoerke JM Conn MT Chang M Chang SY Saiki RK Catanese JJ Leong DU Garcia VE McAllister LB Jeffery DA Lee AT Batliwalla F Remmers E Criswell LA Seldin MF Kastner DL Amos CI Sninsky JJ Gregersen PK Am J Hum Genet 2004 75 2 330 337 1216068 15208781 10.1086/422827 <p>Role of PTPN22 in type 1 diabetes and other autoimmune diseases</p> Bottini N Vang T Cucca F Mustelin T Semin Immunol 2006 16697661 <p>Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene</p> Hinks A Barton A John S Bruce I Hawkins C Griffiths CE Donn R Thomson W Silman A Worthington J Arthritis Rheum 2005 52 6 1694 1699 10.1002/art.21049 15934099 <p>Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis</p> Seldin MF Shigeta R Laiho K Li H Saila H Savolainen A Leirisalo-Repo M Aho K Tuomilehto-Wolf E Kaarela K Kauppi M Alexander HC Begovich AB Tuomilehto J Genes Immun 2005 6 8 720 722 16107870 <p>Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases</p> Viken MK Amundsen SS Kvien TK Boberg KM Gilboe IM Lilleby V Sollid LM Forre OT Thorsby E Smerdel A Lie BA Genes Immun 2005 6 3 271 273 10.1038/sj.gene.6364178 15759012 <p>No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations</p> Cinek O Hradsky O Ahmedov G Slavcev A Kolouskova S Kulich M Sumnik Z Diabetes research and clinical practice 2007 76 2 297 303 10.1016/j.diabres.2006.09.009 17000021 <p>Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection</p> Hadchouel M Prieur AM Griscelli C J Pediatr 1985 106 4 561 566 10.1016/S0022-3476(85)80072-X 3981309 <p>Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis</p> Hazen MM Woodward AL Hofmann I Degar BA Grom A Filipovich AH Binstadt BA Arthritis Rheum 2008 58 2 567 570 10.1002/art.23199 18240215 <p>Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome</p> Grom AA Villanueva J Lee S Goldmuntz EA Passo MH Filipovich A J Pediatr 2003 142 3 292 296 10.1067/mpd.2003.110 12640378 <p>Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome</p> Villanueva J Lee S Giannini EH Graham TB Passo MH Filipovich A Grom AA Arthritis Res Ther 2005 7 1 R30 7 1064882 15642140 10.1186/ar1453 <p>Mutations in the perforin gene may be linked to macrophage activation syndrome in pateints with systemic onset juvenile idiopathic arthritis.</p> Vastert B Van Wijk R D'Urbano LE De Vooght K Ravelli A Cortis E Hoppenreijs EP Van Solinge W Prakken B Wulffraat N De Benedetti F Kuis W Turkish Journal of Pediatrics 2008 50 (Suppl) 2 <p>Macrophage activation syndrome in systemic juvenile idiopathic arthritis is associated with MUNC13-14 gene polymorphisms</p> Zhang K Biroschak J Glass D Thompson SD Finkel T Passo M Binstadt BA Filipovich A Grom A Arthritis Rheum 2008 In press <p>Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis</p> Behrens EM Beukelman T Paessler M Cron RQ J Rheumatol 2007 34 5 1133 1138 17343315 <p>Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis</p> Donn R Ellison S Lamb R Day T Baildam E Ramanan AV Arthritis Rheum 2008 58 3 869 874 10.1002/art.23270 18311812 <p>A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage</p> Thompson SD Moroldo MB Guyer L Ryan M Tombragel EM Shear ES Prahalad S Sudman M Keddache MA Brown WM Giannini EH Langefeld CD Rich SS Nichols WC Glass DN Arthritis Rheum 2004 50 9 2920 2930 10.1002/art.20425 15457461 <p>A genome-wide association study identifies IL23R as an inflammatory bowel disease gene</p> Duerr RH Taylor KD Brant SR Rioux JD Silverberg MS Daly MJ Steinhart AH Abraham C Regueiro M Griffiths A Dassopoulos T Bitton A Yang H Targan S Datta LW Kistner EO Schumm LP Lee AT Gregersen PK Barmada MM Rotter JI Nicolae DL Cho JH Science 2006 314 5804 1461 1463 10.1126/science.1135245 17068223 <p>A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region</p> Smyth DJ Cooper JD Bailey R Field S Burren O Smink LJ Guja C Ionescu-Tirgoviste C Widmer B Dunger DB Savage DA Walker NM Clayton DG Todd JA Nat Genet 2006 38 6 617 619 10.1038/ng1800 16699517 <p>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls</p> Nature 2007 447 7145 661 678 10.1038/nature05911 17554300 <p>Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis</p> Rioux JD Xavier RJ Taylor KD Silverberg MS Goyette P Huett A Green T Kuballa P Barmada MM Datta LW Shugart YY Griffiths AM Targan SR Ippoliti AF Bernard EJ Mei L Nicolae DL Regueiro M Schumm LP Steinhart AH Rotter JI Duerr RH Cho JH Daly MJ Brant SR Nat Genet 2007 39 5 596 604 10.1038/ng2032 17435756 <p>Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants</p> Burton PR Clayton DG Cardon LR Craddock N Deloukas P Duncanson A Kwiatkowski DP McCarthy MI Ouwehand WH Samani NJ Todd JA Donnelly P Barrett JC Davison D Easton D Evans DM Leung HT Marchini JL Morris AP Spencer CC Tobin MD Attwood AP Boorman JP Cant B Everson U Hussey JM Jolley JD Knight AS Koch K Meech E Nutland S Prowse CV Stevens HE Taylor NC Walters GR Walker NM Watkins NA Winzer T Jones RW McArdle WL Ring SM Strachan DP Pembrey M Breen G St Clair D Caesar S Gordon-Smith K Jones L Fraser C Green EK Grozeva D Hamshere ML Holmans PA Jones IR Kirov G Moskivina V Nikolov I O'Donovan MC Owen MJ Collier DA Elkin A Farmer A Williamson R McGuffin P Young AH Ferrier IN Ball SG Balmforth AJ Barrett JH Bishop TD Iles MM Maqbool A Yuldasheva N Hall AS Braund PS Dixon RJ Mangino M Stevens S Thompson JR Bredin F Tremelling M Parkes M Drummond H Lees CW Nimmo ER Satsangi J Fisher SA Forbes A Lewis CM Onnie CM Prescott NJ Sanderson J Matthew CG Barbour J Mohiuddin MK Todhunter CE Mansfield JC Ahmad T Cummings FR Jewell DP Webster J Brown MJ Lathrop MG Connell J Dominiczak A Marcano CA Burke B Dobson R Gungadoo J Lee KL Munroe PB Newhouse SJ Onipinla A Wallace C Xue M Caulfield M Farrall M Barton A Bruce IN Donovan H Eyre S Gilbert PD Hilder SL Hinks AM John SL Potter C Silman AJ Symmons DP Thomson W Worthington J Dunger DB Widmer B Frayling TM Freathy RM Lango H Perry JR Shields BM Weedon MN Hattersley AT Hitman GA Walker M Elliott KS Groves CJ Lindgren CM Rayner NW Timpson NJ Zeggini E Newport M Sirugo G Lyons E Vannberg F Hill AV Bradbury LA Farrar C Pointon JJ Wordsworth P Brown MA Franklyn JA Heward JM Simmonds MJ Gough SC Seal S Stratton MR Rahman N Ban M Goris A Sawcer SJ Compston A Conway D Jallow M Newport M Sirugo G Rockett KA Bumpstead SJ Chaney A Downes K Ghori MJ Gwilliam R Hunt SE Inouye M Keniry A King E McGinnis R Potter S Ravindrarajah R Whittaker P Widden C Withers D Cardin NJ Davison D Ferreira T Pereira-Gale J Hallgrimsdo'ttir IB Howie BN Su Z Teo YY Vukcevic D Bentley D Brown MA Compston A Farrall M Hall AS Hattersley AT Hill AV Parkes M Pembrey M Stratton MR Mitchell SL Newby PR Brand OJ Carr-Smith J Pearce SH McGinnis R Keniry A Deloukas P Reveille JD Zhou X Sims AM Dowling A Taylor J Doan T Davis JC Savage L Ward MM Learch TL Weisman MH Brown M Nat Genet 2007 39 11 1329 1337 10.1038/ng.2007.17 17952073 <p>Two independent alleles at 6q23 associated with risk of rheumatoid arthritis</p> Plenge RM Cotsapas C Davies L Price AL de Bakker PI Maller J Pe'er I Burtt NP Blumenstiel B Defelice M Parkin M Barry R Winslow W Healy C Graham RR Neale BM Izmailova E Roubenoff R Parker AN Glass R Karlson EW Maher N Hafler DA Lee DM Seldin MF Remmers EF Lee AT Padyukov L Alfredsson L Coblyn J Weinblatt ME Gabriel SB Purcell S Klareskog L Gregersen PK Shadick NA Daly MJ Altshuler D Nat Genet 2007 17982456 <p>A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis</p> Kurreeman FA Padyukov L Marques RB Schrodi SJ Seddighzadeh M Stoeken-Rijsbergen G van der Helm-van Mil AH Allaart CF Verduyn W Houwing-Duistermaat J Alfredsson L Begovich AB Klareskog L Huizinga TW Toes RE PLoS medicine 2007 4 9 e278 1976626 17880261 10.1371/journal.pmed.0040278 <p>Rheumatoid arthritis association at 6q23</p> Thomson W Barton A Ke X Eyre S Hinks A Bowes J Donn R Symmons D Hider S Bruce IN Wilson AG Marinou I Morgan A Emery P Carter A Steer S Hocking L Reid DM Wordsworth P Harrison P Strachan D Worthington J Nat Genet 2007 <p>A Whole Genome by Association of Chronic Inflammatory Arthritis</p> John S Hinks A Shephard N Turpaz Y Cargill M Wang E Barton A Eyre S Thomson W Kennedy G Worthington J Arthritis Rheum 2006 54 9 (Suppl) S131 <p>High Density SNP Genome-wide Association Study in Juvenile Idiopathic Arthritis</p> Thompson SD Sudman M Marion MC Srivastava S Keddache MA Langefeld CD Glass D Arthritis Rheum 2007 56 9 (Suppl) S791 <p>Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases</p> Ginn LR Lin JP Plotz PH Bale SJ Wilder RL Mbauya A Miller FW Arthritis Rheum 1998 41 3 400 405 10.1002/1529-0131(199803)41:3<400::AID-ART4>3.0.CO;2-5 9506566 <p>Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus</p> Mihailova D Grigorova R Vassileva B Mladenova G Ivanova N Stephanov S Lissitchky K Dimova E Adv Exp Med Biol 1999 455 55 60 10599323 <p>Endocrine autoimmunity in young patients with juvenile chronic arthritis</p> Alpigiani MG Cerboni M Bertini I d'Annunzio G Haupt R Iester A Lorini R Clin Exp Rheumatol 2002 20 4 565 568 12175117 <p>Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis</p> Stagi S Giani T Simonini G Falcini F Rheumatology (Oxford) 2005 44 4 517 520 10.1093/rheumatology/keh531 15695302 <p>Juvenile rheumatoid arthritis in children with diabetes mellitus</p> Rudolf MC Genel M Tamborlane WV Jr. Dwyer JM J Pediatr 1981 99 4 519 524 10.1016/S0022-3476(81)80246-6 6974234 <p>Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease</p> Ueda H Howson JM Esposito L Heward J Snook H Chamberlain G Rainbow DB Hunter KM Smith AN Di Genova G Herr MH Dahlman I Payne F Smyth D Lowe C Twells RC Howlett S Healy B Nutland S Rance HE Everett V Smink LJ Lam AC Cordell HJ Walker NM Bordin C Hulme J Motzo C Cucca F Hess JF Metzker ML Rogers J Gregory S Allahabadia A Nithiyananthan R Tuomilehto-Wolf E Tuomilehto J Bingley P Gillespie KM Undlien DE Ronningen KS Guja C Ionescu-Tirgoviste C Savage DA Maxwell AP Carson DJ Patterson CC Franklyn JA Clayton DG Peterson LB Wicker LS Todd JA Gough SC Nature 2003 423 6939 506 511 10.1038/nature01621 12724780 <p>Lack of association of functional CTLA4 polymorphisms with juvenile idiopathic arthritis</p> Prahalad S Bohnsack JF Whiting A Clifford B Jorde LB Guthery SL Thompson SD Glass DN Bamshad MJ Arthritis Rheum 2008 58 7 2147 2152 10.1002/art.23602 18576317 <p>Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis</p> Pokorny V McQueen F Yeoman S Merriman M Merriman A Harrison A Highton J McLean L Ann Rheum Dis 2005 64 3 487 490 1755415 15331395 10.1136/ard.2004.023333 <p>A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes</p> Cargill M Schrodi SJ Chang M Garcia VE Brandon R Callis KP Matsunami N Ardlie KG Civello D Catanese JJ Leong DU Panko JM McAllister LB Hansen CB Papenfuss J Prescott SM White TJ Leppert MF Krueger GG Begovich AB Am J Hum Genet 2007 80 2 273 390 1785338 17236132 10.1086/511051 <p>The inflammatory disease-associated variants in IL12B and IL23R are not associated with rheumatoid arthritis</p> Chang M Saiki RK Cantanese JJ Lew D van der Helm-van Mil AH Toes RE Huizinga TW Ardlie KG Criswell LA Seldin MF Amos CI Kastner DL Gregersen PK Schrodi SJ Begovich AB Arthritis Rheum 2008 58 6 1877 1881 10.1002/art.23492 18512797 <p>Investigation of the IL23R gene in a Spanish rheumatoid arthritis cohort</p> Orozco G Rueda B Robledo G Garcia A Martin J Hum Immunol 2007 68 8 681 684 10.1016/j.humimm.2007.05.008 17678723 <p>Investigation in JIA of RA susceptibility SNPs Identified in the WTCCC WGAS reveals Association with IL2RA/CD25</p> Thomson W Hinks A Barton A Ke X Eyre S Bowes J Donn R Hider S Bruce I Wilson AG Morgan A Emery P YEAR Consortium BSPAR group Carter A Steer S Hocking L Reid DM Strachan D Worthington J Arthritis Rheum 2007 56 9 (Suppl) S808 <p>Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis</p> Alsaeid K Haider MZ Ayoub EM J Rheumatol 2003 30 12 2705 2709 14719217 <p>A comprehensive candidate gene study on bronchial asthma and juvenile idiopathic arthritis</p> Schubert K von Bonnsdorf H Burke M Ahlert I Braun S Berner R Deichmann KA Heinzmann A Dis Markers 2006 22 3 127 132 16788246 <p>Direct molecular haplotyping by melting curve analysis of hybridization probes: beta 2-adrenergic receptor haplotypes as an example</p> Pont-Kingdon G Lyon E Nucleic Acids Res 2005 33 10 e89 1142492 15937194 10.1093/nar/gni090 <p>Increased frequency of the MZ phenotype of alpha-1-protease inhibitor in juvenile chronic polyarthritis</p> Arnaud P Galbraith RM Faulk WP J Clin Invest 1977 60 6 1442 1444 372503 334801 10.1172/JCI108906 <p>Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis</p> Donn RP Farhan A Stevans A Ramanan A Ollier WE Thomson W Rheumatology (Oxford) 2002 41 8 930 936 10.1093/rheumatology/41.8.930 12154211 <p>Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases</p> Scheibel I Veit T Neves AG Souza L Prezzi S Machado S Kohem C Icarelli M Xavier R Brenol JC Chies JA Scand J Rheumatol 2008 37 1 13 17 10.1080/03009740701631935 18189189 <p>The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland</p> Suppiah V O'Doherty C Heggarty S Patterson CC Rooney M Vandenbroeck K Exp Mol Pathol 2006 80 2 141 146 10.1016/j.yexmp.2005.09.004 16248997 <p>Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis</p> Viken MK Sollid HD Joner G Dahl-Jorgensen K Ronningen KS Undlien DE Flato B Selvaag AM Forre O Kvien TK Thorsby E Melms A Tolosa E Lie BA Hum Immunol 2007 68 9 748 755 10.1016/j.humimm.2007.05.009 17869649 <p>Linkage and association studies of discoidin domain receptor 1 (DDR1) single nucleotide polymorphisms (SNPs) in juvenile oligoarthritis</p> Zeggini E Reginato AM Prais A Thomson W McLean W Donn R Rheumatology (Oxford) 2004 43 9 1138 1141 10.1093/rheumatology/keh261 15213330 <p>Lack of association between juvenile idiopathic arthritis and fas gene polymorphism</p> Donn R Zeggini E Shelley E Ollier W Thomson W J Rheumatol 2002 29 1 166 168 11824955 <p>The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases</p> Eike MC Nordang GB Karlsen TH Boberg KM Vatn MHATI Dahl-Jorgensen K Ronningen KS Joner G Flato B Bergquist A Thorsby E Forre O Kvien TK Undlien DE Lie BA Ann Rheum Dis 2007 18065500 <p>SNPs in the FOXP3 gene region show no association with Juvenile Idiopathic Arthritis in a UK Caucasian population</p> Eastell T Hinks A Thomson W Rheumatology (Oxford) 2007 46 8 1263 1265 1955685 17526924 10.1093/rheumatology/kem129 <p>GSTT1, GSTM1 and GSTP1 polymorphisms and susceptibility to juvenile idiopathic arthritis</p> Rohr P Veit TD Scheibel I Xavier RM Brenol JC Chies JA Kvitko K Clin Exp Rheumatol 2008 26 1 151 155 18328165 <p>Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population</p> Cinek O Vavrincova P Striz I Drevinek P Sedlakova P Vavrinec J Slavcev A J Rheumatol 2004 31 6 1206 1210 15170937 <p>Textbook of Pediatric Rheumatology</p> Cassidy J Petty RE Laxer RM Lindsley C Philadelphia , W.B. Saunders Company 5th 2005 <p>IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors</p> Cimaz R Cazalis MA Reynaud C Gerloni V Zulian F Biggioggero M Martini G Pontikaki I Fantini F Mougin B Miossec P Ann Rheum Dis 2007 66 7 900 904 10.1136/ard.2006.067454 17324969 <p>Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis</p> Vencovsky J Jarosova K Ruzickova S Nemcova D Niederlova J Ozen S Alikasifoglu M Bakkaloglu A Ollier WE Mageed RA Arthritis Rheum 2001 44 10 2387 2391 10.1002/1529-0131(200110)44:10<2387::AID-ART403>3.0.CO;2-7 11665981 <p>Polymorphisms in the interleukin-4 and IL-4 receptor genes modify risk for chronic inflammatory arthropathies in women</p> Suppiah V Rooney M Vandenbroeck K Exp Mol Pathol 2006 81 3 239 244 10.1016/j.yexmp.2006.02.001 16551465 <p>Novel IL10 gene family associations with systemic juvenile idiopathic arthritis</p> Fife MS Gutierrez A Ogilvie EM Stock CJ Samuel JM Thomson W Mack LF Lewis CM Woo P Arthritis Res Ther 2006 8 5 R148 1779449 16959027 10.1186/ar2041 <p>Polymorphisms within interleukin 15 are associated with juvenile idiopathic arthritis</p> Bierbaum S Sengler C Gerhold K Berner R Heinzmann A Clin Exp Rheumatol 2006 24 2 219 16762172 <p>A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population</p> Sugiura T Maeno N Kawaguchi Y Takei S Imanaka H Kawano Y Terajima-Ichida H Hara M Kamatani N Arthritis Res Ther 2006 8 3 R60 1526617 16563174 10.1186/ar1930 <p>No evidence for genetic association of interferon regulatory factor 1 in juvenile idiopathic arthritis</p> Fife MS Gathercole L Ogilvie EM Stock CJ Mack LF Donn RP Thomson W Woo P Arthritis Rheum 2007 56 3 972 976 10.1002/art.22425 17328074 <p>Polymorphism in the MHC-encoded LMP7 gene: association with JRA without functional significance for immunoproteasome assembly</p> Prahalad S Kingsbury DJ Griffin TA Cooper BL Glass DN Maksymowych WP Colbert RA J Rheumatol 2001 28 10 2320 2325 11669176 <p>Lack of association between mannose-binding lectin gene polymorphisms and juvenile idiopathic arthritis in a Han population from the Hubei province of China</p> Kang M Wang HW Cheng PX Yin ZD Li XO Shi H Hu XF Arthritis Res Ther 2006 8 4 R85 1779397 16681863 10.1186/ar1953 <p>Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis</p> Ozyurek AR Gurses D Ulger Z Levent E Bakiler AR Berdeli A Clin Rheumatol 2007 26 4 546 550 10.1007/s10067-006-0347-6 16835702 <p>Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation?</p> Ozen S Bakkaloglu A Yilmaz E Duzova A Balci B Topaloglu R Besbas N J Rheumatol 2003 30 9 2014 2018 12966608 <p>Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis</p> Day TG Ramanan AV Hinks A Lamb R Packham J Wise C Punaro M Donn RP Arthritis Rheum 2008 58 7 2142 2146 10.1002/art.23604 18576390 <p>The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies</p> O'Doherty C Hawkins S Rooney M Vandenbroeck K Tissue Antigens 2007 70 3 247 251 10.1111/j.1399-0039.2007.00876.x 17661914 <p>Major histocompatibility complex class I chain related (MIC) A gene, TNFa microsatellite alleles and TNFB alleles in juvenile idiopathic arthritis patients from Latvia</p> Nikitina Zake L Cimdina I Rumba I Dabadghao P Sanjeevi CB Hum Immunol 2002 63 5 418 423 10.1016/S0198-8859(02)00385-3 11975986 <p>No evidence for hyperhomocysteinemia or increased prevalence of genetic polymorphisms in the homocysteine pathway in patients with moderate juvenile idiopathic arthritis</p> Huemer M Huemer C Ulmer H Crone J Fodinger M Falger J Sailer-Hock M J Rheumatol 2005 32 1 170 174 15630743 <p>A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis</p> Marciano R Giacopelli F Divizia MT Gattorno M Felici E Pistorio A Martini A Ravazzolo R Picco P Ann Rheum Dis 2006 65 5 662 665 10.1136/ard.2005.040626 16150788 <p>Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene</p> Smerdel A Dai KZ Lorentzen AR Flato B Maslinski S Thorsby E Forre O Spurkland A Genes Immun 2004 5 4 310 312 10.1038/sj.gene.6364093 15129233 <p>Positive association of SLC26A2 gene polymorphisms with susceptibility to systemic-onset juvenile idiopathic arthritis</p> Lamb R Thomson W Ogilvie EM Donn R Arthritis Rheum 2007 56 4 1286 1291 10.1002/art.22444 17393463 <p>The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis</p> Gibbons LJ Thomson W Zeggini E Worthington J Barton A Eyre S Donn R Hinks A Rheumatology (Oxford) 2005 44 11 1390 1393 10.1093/rheumatology/kei041 16159953 <p>Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis</p> Ploski R Undlien DE Vinje O Forre O Thorsby E Ronningen KS Hum Immunol 1994 39 1 54 60 10.1016/0198-8859(94)90101-5 8181963 <p>Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study</p> Bukulmez H Fife M Tsoras M Thompson SD Twine NA Woo P Olson JM Elston RC Glass DN Colbert RA Arthritis Res Ther 2005 7 2 R285 90 1065319 15743475 10.1186/ar1480 <p>Polymorphism in a T-cell receptor variable gene is associated with susceptibility to a juvenile rheumatoid arthritis subset</p> Maksymowych WP Gabriel CA Luyrink L Melin-Aldana H Elma M Giannini EH Lovell DJ Van Kerckhove C Leiden J Choi E Immunogenetics 1992 35 4 257 262 10.1007/BF00166831 1347283 <p>Lack of association with T-cell receptor TCRBV6S1*2 allele in HLA-DQA1*0101-positive Norwegian juvenile chronic arthritis patients</p> Ploski R Hansen T Forre O Immunogenetics 1993 38 6 444 445 10.1007/BF00184525 8406616 <p>Toll-like receptor 4 gene polymorphisms and susceptibility to juvenile idiopathic arthritis</p> Lamb R Zeggini E Thomson W Donn R Ann Rheum Dis 2005 64 5 767 769 1755476 15498795 10.1136/ard.2004.026930 <p>TNF-alpha promoter gene polymorphisms in Spanish children with persistent oligoarticular and systemic-onset juvenile idiopathic arthritis</p> Modesto C Patino-Garcia A Sotillo-Pineiro E Merino J Garcia-Consuegra J Merino R Rua MJ Sierrasesumaga L Arnal C Scand J Rheumatol 2005 34 6 451 454 10.1080/03009740510026652 16393767 <p>Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis</p> Zeggini E Thomson W Alansari A Ollier W Donn R Rheumatology (Oxford) 2002 41 4 462 465 10.1093/rheumatology/41.4.462 11961180 <p>Association of the TRAF1-C5 locus on chromosome 9 with juvenile idiopathic arthritis</p> Behrens EM Finkel TH Bradfield JP Kim CE Linton L Casalunovo T Frackelton EC Santa E George Otieno F Glessner JT Chiavacci RM Grant SF Hakonarson H Arthritis Rheum 2008 58 7 2206 2207 10.1002/art.23603 18576341